A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
NCT05571943
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
542
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Difamilast
Sponsor
Acrotech Biopharma Inc.